Antioxidants (May 2021)

Distinction between 2′- and 3′-Phosphate Isomers of a Fluorescent NADPH Analogue Led to Strong Inhibition of Cancer Cells Migration

  • Raoul Manuel,
  • Michelle de Souza Lima,
  • Sébastien Dilly,
  • Sylvain Daunay,
  • Patricia Abbe,
  • Elodie Pramil,
  • Stéphanie Solier,
  • Fabienne Guillaumond,
  • Sarah-Simha Tubiana,
  • Alexandre Escargueil,
  • João Antonio Pêgas Henriques,
  • Nathalie Ferrand,
  • Irène Erdelmeier,
  • Jean-Luc Boucher,
  • Gildas Bertho,
  • Israel Agranat,
  • Stéphane Rocchi,
  • Michèle Sabbah,
  • Anny Slama Schwok

DOI
https://doi.org/10.3390/antiox10050723
Journal volume & issue
Vol. 10, no. 5
p. 723

Abstract

Read online

Specific inhibition of NADPH oxidases (NOX) and NO-synthases (NOS), two enzymes associated with redox stress in tumor cells, has aroused great pharmacological interest. Here, we show how these enzymes distinguish between isomeric 2′- and 3′-phosphate derivatives, a difference used to improve the specificity of inhibition by isolated 2′- and 3′-phosphate isomers of our NADPH analogue NS1. Both isomers become fluorescent upon binding to their target proteins as observed by in vitro assay and in vivo imaging. The 2′-phosphate isomer of NS1 exerted more pronounced effects on NOS and NOX-dependent physiological responses than the 3′-phosphate isomer did. Docking and molecular dynamics simulations explain this specificity at the level of the NADPH site of NOX and NOS, where conserved arginine residues distinguished between the 2′-phosphate over the 3′-phosphate group, in favor of the 2′-phosphate.

Keywords